相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabotropic and Ionotropic Glutamate Receptors Mediate the Modulation of Acetylcholine Release at the Frog Neuromuscular Junction
Andrei Tsentsevitsky et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2017)
Role of Glutamate and NMDA Receptors in Alzheimer's Disease
Rui Wang et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
A slow excitatory postsynaptic current mediated by a novel metabotropic glutamate receptor in CA1 pyramidal neurons
Nengyin Sheng et al.
NEUROPHARMACOLOGY (2017)
Memantine Treatment in Patients with Mild to Moderate Alzheimer's Disease: Results of a Randomised, Double-Blind, Placebo-Controlled 6-Month Study
S. Bakchine et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Cell cycle activation in p21 dependent pathway: An alternative mechanism of organophosphate induced dopaminergic neurodegeneration
Willayat Yousuf Wani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease
Subbiah Pugazhenthi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Understanding Aspects of Aluminum Exposure in Alzheimer's Disease Development
Ramesh Kandimalla et al.
BRAIN PATHOLOGY (2016)
A(2A) adenosine receptor deletion is protective in a mouse model of Tauopathy (vol 21, pg 149, 2016)
C. Laurent et al.
MOLECULAR PSYCHIATRY (2016)
Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems
Laszlo Koeles et al.
PURINERGIC SIGNALLING (2016)
Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases
Bassem Sadek et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis
Ramesh Kandimalla et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Smad3 deficiency inhibits dentate gyrus LTP byenhancing GABAA neurotransmission
Ma Dolores Munoz et al.
JOURNAL OF NEUROCHEMISTRY (2016)
α7-nAChR agonist enhances neural plasticity in the hippocampus via a GABAergic circuit
Matthew Townsend et al.
JOURNAL OF NEUROPHYSIOLOGY (2016)
Neuronal histamine and cognitive symptoms in Alzheimer's disease
Armin Zlomuzica et al.
NEUROPHARMACOLOGY (2016)
Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse
Gustavo Provensi et al.
NEUROPHARMACOLOGY (2016)
Understanding the Bases of Function and Modulation of α7 Nicotinic Receptors: Implications for Drug Discovery
Jeremias Corradi et al.
MOLECULAR PHARMACOLOGY (2016)
Adenosine A2A receptors are necessary and sufficient to trigger memory impairment in adult mice
N. Pagnussat et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Amyloid-β Impairs Synaptic Inhibition via GABAA Receptor Endocytosis
Daniel Ulrich
JOURNAL OF NEUROSCIENCE (2015)
The human histaminergic system in neuropsychiatric disorders
Ling Shan et al.
TRENDS IN NEUROSCIENCES (2015)
Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss
J. H. Birnbaum et al.
CELL DEATH & DISEASE (2015)
Serotonin 6 receptor controls alzheimer's disease and depression
Hyung-Mun Yun et al.
ONCOTARGET (2015)
Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis
Jun Wang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
Ramesh J. Kandimalla et al.
CURRENT ALZHEIMER RESEARCH (2014)
A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H-3 Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer's Disease
Richard A. Grove et al.
CURRENT ALZHEIMER RESEARCH (2014)
Impaired spatial learning and reduced adult hippocampal neurogenesis in histamine H1-receptor knockout mice
Oliver Ambree et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease
Seonmi Jo et al.
NATURE MEDICINE (2014)
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand et al.
NEUROPHARMACOLOGY (2014)
Modulation of behavior by the histaminergic system: Lessons from H1R-and H2R-deficient mice
Erich H. Schneider et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Modulation of behavior by the histaminergic system: Lessons from HDC-, H3R- and H4R-deficient mice
Erich H. Schneider et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2014)
Focus on GABAA receptor function A comparative analysis of in vivo imaging studies in neuropsychiatric disorders
S. Nikolaus et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2014)
Neuronal failure in Alzheimer's disease: a view through the oxidative stress looking-glass
David J. Bonda et al.
NEUROSCIENCE BULLETIN (2014)
Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease
Jing-ying Jia et al.
ACTA PHARMACOLOGICA SINICA (2013)
The Neglected Role of Histamine in Alzheimer's Disease
Fatemeh Naddafi et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2013)
The histamine H3-receptor inverse agonist Pitolisant improves fear memory in mice
Christian Brabant et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H3 Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Pradeep J. Nathan et al.
Current Alzheimer Research (2013)
Glutamate Receptors in Human Caudate Nucleus in Normal Aging and Alzheimer's Disease
Konstantinos I. Tsamis et al.
CURRENT ALZHEIMER RESEARCH (2013)
Sigma receptor modulators: a patent review
Simona Collina et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Bioenergetic flux, mitochondrial mass and mitochondrial morphology dynamics in AD and MCI cybrid cell lines
Diana F. Silva et al.
HUMAN MOLECULAR GENETICS (2013)
Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus
Abu Syed Md Anisuzzaman et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Glutamate system, amyloid beta peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology
Timothy J. Revett et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2013)
Functional roles of neurotransmitters and neuromodulators in the dorsal striatum
Jeehaeh Do et al.
LEARNING & MEMORY (2013)
Blockade of Tau Hyperphosphorylation and Aβ1-42 Generation by the Aminotetrahydrofuran Derivative ANAVEX2-73, a Mixed Muscarinic and σ1 Receptor Agonist, in a Nontransgenic Mouse Model of Alzheimer's Disease
Valentine Lahmy et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Memantine and Cholinesterase Inhibitors: Complementary Mechanisms in the Treatment of Alzheimer's Disease
Chris G. Parsons et al.
NEUROTOXICITY RESEARCH (2013)
The histamine H1 receptor and recollection-based discrimination in a temporal order memory task in the mouse
Armin Zlomuzica et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2013)
Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer's Disease: A Review of Clinical Trials
Ivana Molino et al.
SCIENTIFIC WORLD JOURNAL (2013)
Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapy
Alireza Atri et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
Valentina Echeverria et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
α7 Nicotinic Acetylcholine Receptors in Alzheimer's Disease: Neuroprotective, Neurotrophic or Both?
Caterina M. Hernandez et al.
CURRENT DRUG TARGETS (2012)
Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD
Rainer Hellweg et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2012)
Cholinergic modulation of amyloid precursor protein processing with emphasis on M1 muscarinic receptor: perspectives and challenges in treatment of Alzheimer's disease
Abraham Fisher
JOURNAL OF NEUROCHEMISTRY (2012)
Alterations in the histaminergic system in Alzheimer's disease: a postmortem study
Ling Shan et al.
NEUROBIOLOGY OF AGING (2012)
Distribution of Serotonin Receptor of Type 6 (5-HT6) in Human Brain Post-mortem. A Pharmacology, Autoradiography and Immunohistochemistry Study
Donatella Marazziti et al.
NEUROCHEMICAL RESEARCH (2012)
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Marina R. Picciotto et al.
NEURON (2012)
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
Jos Prickaerts et al.
NEUROPHARMACOLOGY (2012)
Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease
Robert Howard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Memantine Inhibits α3β2-nAChRs-Mediated Nitrergic Neurogenic Vasodilation in Porcine Basilar Arteries
Reggie Hui-Chao Lee et al.
PLOS ONE (2012)
Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Yunqi Xu et al.
PROGRESS IN NEUROBIOLOGY (2012)
The serotonergic system in ageing and Alzheimer's disease
Jose Julio Rodriguez et al.
PROGRESS IN NEUROBIOLOGY (2012)
Postsynaptic receptors for arnyloid-β oligomers as mediators of neuronal damage in Alzheimer's disease
Margarita C. Dinamarca et al.
FRONTIERS IN PHYSIOLOGY (2012)
siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells
Ramesh J. L. Kandimalla et al.
JOURNAL OF BIOMEDICAL SCIENCE (2012)
Loss of Muscarinic M1 Receptor Exacerbates Alzheimer's Disease-Like Pathology and Cognitive Decline
Rodrigo Medeiros et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Lack of Evidence for the Efficacy of Memantine in Mild Alzheimer Disease
Lon S. Schneider et al.
ARCHIVES OF NEUROLOGY (2011)
Cholinergic influences on cortical development and adult neurogenesis
Elodie Bruel-Jungerman et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: Involvement of dopamine D2 and 5-HT2A receptors
Kota Nakaya et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The cholinergic system and hippocampal plasticity
Benjamin D. Drever et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Discovery and optimization of a novel, selective and brain penetrant M1 positive allosteric modulator (PAM): The development of ML169, an MLPCN probe
Paul R. Reid et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
The histamine H3 receptor: from discovery to clinical trials with pitolisant
Jean-Charles Schwartz
BRITISH JOURNAL OF PHARMACOLOGY (2011)
EHT0202 in Alzheimer's Disease: A 3-Month, Randomized, Placebo-Controlled, Double-Blind Study
B. Vellas et al.
CURRENT ALZHEIMER RESEARCH (2011)
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study
Gareth Maher-Edwards et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)
Activation of Brain Histaminergic Neurotransmission: A Mechanism for Cognitive Effects of Memantine in Alzheimer's Disease
M. Motawaj et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease
R. Scott Bitner et al.
NEUROPHARMACOLOGY (2011)
5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment
Fei Shen et al.
NEUROPHARMACOLOGY (2011)
Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients
Ramesh J. L. Kandimalla et al.
NEUROSCIENCE LETTERS (2011)
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Paula I. Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Nicotinic Acetylcholine Receptor Interaction with β-Amyloid: Molecular, Cellular, and Physiological Consequences
H. R. Parri et al.
CURRENT ALZHEIMER RESEARCH (2010)
Double-Blind, Controlled Phase II Study of a 5-HT6 Receptor Antagonist, SB-742457, in Alzheimer's Disease
G. Maher-Edwards et al.
CURRENT ALZHEIMER RESEARCH (2010)
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors
Luca Rozzini et al.
INTERNATIONAL PSYCHOGERIATRICS (2010)
Memogain is a Galantamine Pro-drug having Dramatically Reduced Adverse Effects and Enhanced Efficacy
Alfred Maelicke et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
In the Adult Hippocampus, Chronic Nerve Growth Factor Deprivation Shifts GABAergic Signaling from the Hyperpolarizing to the Depolarizing Direction
Laura Lagostena et al.
JOURNAL OF NEUROSCIENCE (2010)
Oxidative stress in Alzheimer disease: A possibility for prevention
David J. Bonda et al.
NEUROPHARMACOLOGY (2010)
Preclinical and clinical pharmacology of the GABA(A) receptor alpha 5 subtype-selective inverse agonist alpha 5IA
John R. Atack
PHARMACOLOGY & THERAPEUTICS (2010)
The Histaminergic System: a Target for Innovative Treatments of Cognitive Deficits.
Mouhammad Motawaj et al.
THERAPIE (2010)
Safety, tolerability, pharmacokinetics and pharmacodynamics of ascending single and multiple doses of lecozotan in healthy young and elderly subjects
Alain Patat et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice
A. D. Medhurst et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Histamine H1 receptor knockout mice exhibit impaired spatial memory in the eight-arm radial maze
A. Zlomuzica et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Functional Expression of Nicotinic Acetylcholine Receptors in Rat Neocortical Layer 5 Pyramidal Cells
Gerd Zolles et al.
CEREBRAL CORTEX (2009)
Effect of a Serotonin Reuptake Inhibitor on Irritability, Apathy, and Psychotic Symptoms in Patients With Alzheimer's Disease
Haroon Siddique et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
β-Amyloid Cortical Deposits Are Accompanied by the Loss of Serotonergic Neurons in the Dog
Vanessa Bernedo et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2009)
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O. L. Lopez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Adenosine A2A Receptor Blockade Prevents Synaptotoxicity and Memory Dysfunction Caused by β-Amyloid Peptides via p38 Mitogen-Activated Protein Kinase Pathway
Paula M. Canas et al.
JOURNAL OF NEUROSCIENCE (2009)
Potency, voltage-dependency, agonist concentration-dependency, blocking kinetics and partial untrapping of the uncompetitive N-methyl-D-aspartate (NMDA) channel blocker memantine at human NMDA (GluN1/GluN2A) receptors
Kate E. Gilling et al.
NEUROPHARMACOLOGY (2009)
5-HT7 receptors in the modulation of cognitive processes
Agata Cifariello et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Alzheimer Disease and the Role of Free Radicals in the Pathogenesis of the Disease
George Perry et al.
CNS & Neurological Disorders-Drug Targets (2008)
Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
Anton P. Porsteinsson et al.
CURRENT ALZHEIMER RESEARCH (2008)
Pharmacodynamics of Memantine: An Update
C. Parsons et al.
Current Neuropharmacology (2008)
The histamine H1-receptor mediates the motivational effects of novelty
A. Zlomuzica et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
Reinaldo Naoto Takahashi et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Etazolate, a neuroprotective drug linking GABAA receptor pharmacology to amyloid precursor protein processing
M. Marcade et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer's Disease
Ying Liu et al.
JOURNAL OF NEUROSCIENCE (2008)
Caffeine, adenosine receptors, memory and Alzheimer disease
Rodrigo A. Cunha
MEDICINA CLINICA (2008)
EPISODIC-LIKE AND PROCEDURAL MEMORY IMPAIRMENTS IN HISTAMINE H1 RECEPTOR KNOCKOUT MICE COINCIDE WITH CHANGES IN ACETYLCHOLINE ESTERASE ACTIVITY IN THE HIPPOCAMPUS AND DOPAMINE TURNOVER IN THE CEREBELLUM
E. Dere et al.
NEUROSCIENCE (2008)
Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease
Abraham Fisher
NEUROTHERAPEUTICS (2008)
A role for the 5-HT1A, 5-HT4 and 5-HT6 receptors in learning and memory
Madeleine V. King et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Non-cholinergic effects of huperzine A: Beyond inhibition of acetylcholinesterase
Hai Yan Zhang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2008)
Pharmacokinetics and pharmacodynamics of the novel daily rivastigmine transdermal patch compared with twice-daily capsules in Alzheimer's disease patients
G. Lefevre et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Adenosine A2A receptors and brain injury:: Broad spectrum of neuroprotection, multifaceted actions and fine tuning modulation
Jiang-Fan Chen et al.
PROGRESS IN NEUROBIOLOGY (2007)
GABAA receptors in aging and Alzheimer's disease
Robert A. Rissman et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Memantine:: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutarnatergic system -: too little activation is bad, too much is even worse
Chris G. Parsons et al.
NEUROPHARMACOLOGY (2007)
Increased autophagic degradation mitochondria in Alzheimer disease
Paula I. Moreira et al.
AUTOPHAGY (2007)
A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease
B. Winblad et al.
NEUROLOGY (2007)
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice
Oscar P. Dall'Igna et al.
EXPERIMENTAL NEUROLOGY (2007)
Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine
Matthias W. Riepe et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain β-amyloid production
G. W. Arendash et al.
NEUROSCIENCE (2006)
The significance of the cholinergic system in the brain during aging and in Alzheimer's disease
R. Schliebs et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Memantine treatment in mild to moderate Alzheimer disease: A 24-week randomized, controlled trial
Elaine R. Peskind et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Functional in vitro characterization of CR 3394:: A novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist
G Losi et al.
NEUROPHARMACOLOGY (2006)
Mechanism of action of memantine
JW Johnson et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment
T Dantoine et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2006)
Lecozotan (SRA-333): A selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties
LE Schechter et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Serotonin 5-HT4 receptors and their mRNAs in rat and guinea pig brain:: Distribution and effects of neurotoxic lesions
MT Vilaró et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Memantine blocks α7*nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons
Y Aracava et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Oxidative imbalance in Alzheimer's disease
XW Zhu et al.
MOLECULAR NEUROBIOLOGY (2005)
Adenosine and brain function
BB Fredholm et al.
INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 63 (2005)
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil - A randomized controlled trial
PN Tariot et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression
M Hendricksen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil
SI Finkel et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2004)
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
W Danysz et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
The cholinergic basal forebrain system during development and its influence on cognitive processes: important questions and potential answers
J Berger-Sweeney
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2003)
Nucleus-specific alteration of raphe neurons in human neurodegenerative disorders
GG Kovacs et al.
NEUROREPORT (2003)
Inhibition of human alpha 7 nicotinic acetylcholine receptors by open channel blockers of N-methyl-D-aspartate receptors
PD Maskell et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The glutamatergic system and Alzheimer's disease - Therapeutic implications
DA Butterfield et al.
CNS DRUGS (2003)
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
SA Lyness et al.
NEUROBIOLOGY OF AGING (2003)
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)
JJ Miguel-Hidalgo et al.
BRAIN RESEARCH (2002)
AF150(S) and AF267B - M1 muscarinic agonists as innovative therapies for Alzheimer's disease
A Fisher et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Does caffeine intake protect from Alzheimer's disease?
L Maia et al.
EUROPEAN JOURNAL OF NEUROLOGY (2002)
Molecular Rearrangements of the extracellular vestibule in NMDAR channels during gating
AI Sobolevsky et al.
NEURON (2002)
Histamine function in brain disorders
L Fernández-Novoa et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
The N-methyl-D-aspartate receptor channel blockers memantine, MRZ 2/579 and other amino-alkyl-cyclohexanes antagonise 5-HT3 receptor currents in cultured HEK-293 and N1E-115 cell systems in a non-competitive manner
G Rammes et al.
NEUROSCIENCE LETTERS (2001)
Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: Effects on the course of Alzheimer's disease
J Coyle et al.
BIOLOGICAL PSYCHIATRY (2001)
Adenosine:: does it have a neuroprotective role after all?
A de Mendonça et al.
BRAIN RESEARCH REVIEWS (2000)
Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes
CPLH Chen et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2000)
Histamine H-1 receptors in patients with Alzheimer'sdisease assessed by positron emission tomography
M Higuchi et al.
NEUROSCIENCE (2000)
分享论文
